Gender-related factors can influence management decisions, treatment outcomes and the overall long-term wellbeing of people living with HIV (PLWH). The Women Against Viruses in Europe (WAVE) Working Group was established to promote the health and wellbeing of women living with HIV (WLWH). WAVE is part of the European AIDS Clinical Society (EACS) and organizes annual workshops to discuss different issues in the management of WLWH.
Introduction
Gender-related factors can influence management decisions, treatment outcomes and the overall long-term wellbeing of people living with HIV (PLWH). Access to HIV testing and engagement with and retention in care may be jeopardized by factors that differ for men and women [1] [2] [3] [4] . Women Against Viruses in Europe (WAVE) was established in 2014, and its main focus is to understand how these factors affect women living with HIV (WLWH), with the aim of promoting high standards of care for WLWH across Europe. Identification of significant data gaps should inform this work, reflecting the fact that WLWH are generally underrepresented in research studies and clinical trials [5] . Cohort initiatives focusing on WLWH across Europe are sparse, yet urgently needed in order to inform standards of clinical management [6] .
Women Against Viruses in Europe was initiated to promote the welfare of HIV-positive women in Europe (http://www.eacsociety.org/wave/about-wave/wave.html). The initiative involves health care professionals, researchers and community representatives. WAVE endeavours to promote equality of access to care and excellence of standards of care for WLWH, and to deliver and support targeted educational programmes. This is in line with recent European AIDS Clinical Society (EACS) initiatives to promote benchmarking of standards of care for PLWH across Europe [7, 8] .
Membership is open to all health care professionals with expertise in HIV and junior care providers are encouraged to join and participate. Members of the community and advocacy groups, industry employees, and others may join WAVE based on their interest or expertise in issues relating to women, regardless of gender or geographical location.
In order to achieve its mission, WAVE organizes annual workshops to discuss different issues in the management of WLWH (http://www.eacsociety.org/wave/wa ve-workshops/wave-workshop.html). The second WAVE workshop took place at the EACS Standard of Care for HIV and Co-infections in Europe meeting held in November 2016 in Brussels, Belgium. This position statement outlines the key points that emerged during the 2016 WAVE workshop and makes recommendation underpinning the work plan.
Methods
During the meeting in Brussels, 34 WAVE members, community representatives and a broad mix of HIV clinicians focused on standards of care for WLWH and reviewed current guidelines.
Participants were divided into three groups: Group 1 reviewed existing data and discussed access to and engagement and retention in care; Group 2 reviewed issues related to monitoring of WLWH on antiretroviral therapy and management of comorbidities; and Group 3 reviewed the current EACS treatment guidelines. Each group received a list of topics for discussion (Supporting Information Notes S1) and members of the group prepared a summary of the various topics for discussion during the workshop. It was decided a priori that the group should suggest additions or revisions within existing guidelines rather than create a separate guideline for women.
After the parallel groups' sessions, all participants joined together to discuss and decide on key areas that should be addressed in future editions of the EACS guidelines. A decision was made to publish a summary of our discussions, which is the content of this paper.
Results
Five key areas were identified to optimize the care for WLWH, as outlined in Table 1 .
Psychosocial aspects of HIV diagnosis and care
Psychosocial factors including actual and perceived stigma may contribute to delayed HIV testing and antiretroviral therapy initiation and contribute to suboptimal adherence and engagement in medical care among WLWH [9] [10] [11] [12] [13] [14] . Some of the determinants comprise gender-based power imbalances, risk of partner violence, racism and sexism [15] . Women may not perceive themselves to be at risk of acquiring HIV, resulting in delayed testing, and the current health care models focusing on men may limit women's access to routine HIV testing [16, 17] . Another important issue is the lack of awareness of some health care providers (HCPs) that they should offer tests to women who have indicator conditions for HIV infection but who do not have obvious risk factors for HIV acquisition [18] .
Young WLWH are emerging as a particularly vulnerable group across Europe, with suboptimal engagement in care and higher rates of antiretroviral treatment interruption [19] . Particularly high rates of loss to follow-up have been reported in WLWH following pregnancy [20, 21] . Care models linking women's services and HIV care have the potential to improve long-term outcomes -for example, post-natal or paediatric services can support WLWH in the post-natal period. HIV infection may first present in postmenopausal women, and in this population it frequently presents late [22] [23] [24] . Women-only clinics have been proved successful in some settings, although they may not necessarily be appropriate for all countries [25] . Further research is needed to identify factors influencing women's ability to access HIV testing and to optimally engage in long-term HIV care. It is of great importance to encourage, involve and strengthen the female community representation across EACS initiatives. WAVE recommendations regarding psychosocial aspects of HIV diagnosis and care are presented in Table 2 .
Mental health in HIV-positive women's care
During this workshop, participants highlighted the huge impact of women's mental health on the women's lives and their treatment outcomes. These professional experiences are confirmed by a global survey showing a 3.5-fold increase in mental health problems of women following their HIV diagnosis [26] . Depression has been shown to be a significant, underdiagnosed determinant of worse adherence and virological responses, regardless of gender [27, 28] . As women experience a disproportionate burden of mental health issues, improving mental health seems to be key to improve treatment outcomes in WLWH [29, 30] . From this perspective, building skills and knowledge in local psychiatric and psychology services to diagnose and manage mental health problems in WLWH is crucial. In women with no serious mental health conditions, peer support can be a possibility to address mental health issues, particularly where access to mental health care services is limited [31] . It is important to underline the need for such services and the scale of mental health problems among WLWH with a migration background [32] . In all settings, partner notification and disclosure remain particularly important issues in WLWH. Further research is required to define the best model of delivering mental health services in different settings. WAVE recommendations regarding mental health are presented in Table 3 .
Pharmacokinetics, toxicity and tolerability of antiretroviral therapy
It is well recognized that body composition, body weight and endogenous/exogenous hormone levels influence the pharmacokinetics of antiretroviral therapy among WLWH [33] . This may affect tolerability, toxicity, and potentially the efficacy of antiretroviral therapy, and this should be considered when selecting drug regimens. Previous studies have indicated that women have an increased risk of antiretroviral therapy toxicity and treatment interruption following an adverse event [34, 35] . While some of these data were obtained with older regimens, two recent studies that only enrolled women also showed differences in efficacy/tolerability of current regimens [36, 37] . WAVE recommendations regarding pharmacokinetics, toxicity and tolerability are presented in Table 4 .
Coinfections and comorbidities
During the WAVE workshop, clinicians expressed the need for a greater understanding around diagnosis and HCP, health care provider. [38] . Little is known about the prevalence of age-related health conditions among WLWH, including symptoms of the menopause [39] . Perimenopausal symptoms can be mistaken for drugrelated side effects, influence adherence or lead to unnecessary treatment switches. Clinicians do not routinely scan or counsel for menopausal symptoms and women commonly misinterpret them. WAVE recommendations regarding coinfections, comorbidities and menopause are presented in Table 5 .
Sexual and reproductive health, and pregnancy
A thorough approach to sexual and reproductive health and pregnancy is needed for WLWH to optimize their health, and the health of their children and families. Such an approach should consider ideal care during the pre-partum, peri-partum and post-partum stages for WLWH. Ensuring that WLWH are asked about their reproductive goals at HIV diagnosis and in follow-up and receive appropriate and ongoing reproductive counselling is crucial. Also, providing contraception and family planning counselling is essential if pregnancy is not currently desired. All current guidelines recommend universal antiretroviral therapy initiation promptly following the HIV diagnosis, irrespective of gender. However, there is lack of consistency regarding when to start antiretroviral therapy in pregnancy across different guidelines. While pregnancy registries assist clinicians in selecting antiretroviral therapy in pregnancy, some data gaps still exist for newer drugs [1] . In addition, there is a lack of clear guidance on the management of WLWH who wish to breast feed, and how to best support WLWH when avoidance of breast feeding creates issues related to fear of disclosure and stigma.
Multidisciplinary teams for sexual and reproductive health care are necessary to respond to the specific needs of WLWH. Patient-centred care models should be prioritized in order to reduce the number of clinic visits, for example, incorporating family planning, reproductive counselling, paediatric services, cervical cancer screening and psychological services during the same visit in the clinic [40] . One of the vulnerable periods for WLWH to drop out of care is the post-partum period [20] . Therefore, linkage of paediatric HIV follow-up with HIV care of the mothers is desirable and could be achieved by providing child-friendly consultation facilities. However, more studies are needed in regard to post-pregnancy retention in HIV care across Europe [41] .
It is important to stress that testing for HIV in pregnancy remains unsatisfactory in many European countries, as is linking women who test HIV-positive in gynaecological clinics to long-term HIV care [42] . In countries where gynaecological services are separate from HIV services, late booking for antenatal care remains an important factor contributing to the risk of vertical HIV transmission [43] . Partners' testing of HIV-positive women and -where appropriate -repeated HIV testing of HIV-negative women in late pregnancy are important strategies to reduce the risk of HIV transmission during pregnancy [44] . WAVE recommendations regarding sexual and reproductive health and pregnancy are presented in Table 6 .
Conclusions
This position statement underlines the key discussion points that emerged during the 2016 WAVE workshop and highlights areas for further research and for womenfocused clinical care. The EACS clinical guidelines, version 9, published in October 2017, have taken up the considerations that were suggested by the WAVE workshop. HCP, health care provider; HCV, hepatitis C virus; HRT, hormone replacement therapy; WLWH, women living with HIV. WLWH, women living with HIV.
